📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
520 announcements match the current filters (relevance ≥ 5).
Waaree Energies Q3 Revenue Jumps 104% YoY to ₹6,291 Cr; PAT at ₹1,009 Cr Amid US Legal Provision
Waaree Energies reported a massive 104% YoY increase in standalone revenue to ₹6,290.95 crore for the quarter ended December 2025. Net profit reached ₹1,009.48 crore, which includes a significant exceptional hit of ₹294.78 crore due to a U.S. Customs investigation regarding export component origins. The company also disclosed an ongoing Income Tax investigation from November 2025. Despite these regulatory challenges, the core business shows strong momentum with Profit Before Tax (before exceptions) growing over 150% YoY.
Key Highlights
Standalone Revenue from operations surged 104% YoY to ₹6,290.95 crore in Q3 FY26.
Net Profit for the quarter stood at ₹1,009.48 crore, up 114% YoY but down 13% sequentially.
Recognized an exceptional provision of ₹294.78 crore for potential U.S. Customs (CBP) liabilities.
Total Income for the nine-month period ended Dec 2025 reached ₹15,399.33 crore.
The company has utilized ₹1,464.89 crore of its IPO proceeds towards manufacturing expansion and corporate purposes.
👀 What to Watch
While operational growth is exceptional, the U.S. CBP investigation and Income Tax probe are key monitorables that could impact future cash flows and sentiment. Long-term investors should focus on the robust revenue growth but remain cautious of regulatory volatility in the short term.
RS Software Reports Q3 FY26 Net Loss of ₹8.07 Cr as Revenue Drops 58% YoY
RS Software reported a weak set of results for the quarter ended December 31, 2025, with revenue from operations falling to ₹5.35 crore from ₹12.68 crore in the same period last year. The company posted a net loss of ₹8.07 crore for the quarter, a significant decline from the marginal profit of ₹0.06 crore recorded in Q3 FY25. For the nine-month period ending December 2025, the company has incurred a total loss of ₹16.54 crore compared to a profit of ₹8.95 crore in the previous year. The decline is primarily driven by a sharp 74% drop in revenue from the USA segment.
Key Highlights
Revenue from operations declined 57.8% YoY to ₹535.03 Lacs in Q3 FY26.
Net loss widened to ₹807.21 Lacs for the quarter against a profit of ₹6.29 Lacs in Q3 FY25.
USA segment revenue plummeted from ₹782.87 Lacs to ₹203.87 Lacs YoY.
9M FY26 total revenue stands at ₹19.19 crore, down significantly from ₹48.64 crore in 9M FY25.
The company reported a negative EPS of ₹3.12 for the quarter compared to ₹0.02 in the year-ago period.
👀 What to Watch
Investors should exercise caution as the company has transitioned into significant losses with a major revenue contraction in its primary US market. It is advisable to monitor management's commentary regarding the recovery of the US business and cost-optimization measures.
Waaree Energies Bags 2,210 MW Solar Module Orders Across India and US Markets
Waaree Energies has secured two major solar module supply contracts totaling 2,210 MW from renowned renewable energy developers. The domestic order involves 210 MW of DCR modules for delivery in FY 2026-27. Additionally, its US subsidiary, Waaree Solar Americas Inc., has bagged a massive 2,000 MW order for utility-scale projects in the United States, with delivery scheduled between 2028 and 2030. These orders significantly enhance the company's order book and provide long-term revenue visibility.
Key Highlights
Secured a 210 MW DCR solar module order for the domestic Indian market for FY 2026-27
Subsidiary Waaree Solar Americas Inc. won a 2,000 MW order from a US utility-scale developer
International order delivery is spread over three years from 2028 to 2030
Total order volume of 2,210 MW demonstrates strong global and domestic demand
Contracts awarded by renowned developers in the renewable power and energy storage sectors
👀 What to Watch
Investors should view this as a strong positive for long-term growth and revenue visibility. The stock remains a key play in the renewable energy manufacturing sector, though execution of the large-scale US order will be a critical monitorable.
Waaree Renewable Bags INR 37.96 Crore EPC Order for 10 MWac Solar Project
Waaree Renewable Technologies Limited (WAAREERTL) has secured a domestic EPC contract for a 10 MWac/14 MWp ground-mount solar PV plant in Uttar Pradesh. The contract is valued at approximately INR 37.96 crore (excluding taxes) and was awarded by a manufacturer of industrial gases. The project is scheduled for completion during the 2026-27 financial year. This win continues the company's momentum in the renewable energy infrastructure segment, providing revenue visibility for the upcoming fiscal years.
Key Highlights
New turnkey EPC contract for a 10 MWac/14 MWp solar plant in Uttar Pradesh.
Total contract value estimated at approximately INR 37.96 crore excluding taxes.
Project awarded by a domestic industrial gas manufacturer with no promoter interest involved.
Scheduled for completion during the financial year 2026-27.
👀 What to Watch
Investors should view this as a positive development that strengthens the order book; maintain focus on the company's execution efficiency and upcoming quarterly results.
Amara Raja Energy & Mobility Appoints Narayan Sudhakar Choudhary as Chief Operations Officer
Amara Raja Energy & Mobility (ARE&M) has appointed Mr. Narayan Sudhakar Choudhary as the Chief Operations Officer effective January 19, 2026. He succeeds Mr. C. Narasimhulu Naidu, who will be retiring in the next couple of months after a planned transition period. Mr. Choudhary brings extensive experience from leadership roles at Honeywell, Tata Toyo, and Autoliv, specializing in manufacturing excellence and Industry 4.0. This move is aimed at ensuring a seamless handover of operational responsibilities as the company continues its focus on the energy and mobility sectors.
Key Highlights
Mr. Narayan Sudhakar Choudhary appointed as COO effective January 19, 2026
Outgoing COO Mr. C. Narasimhulu Naidu to superannuate after a transition period of 2 months
New COO joins from Taco Punch Powertrain with prior experience at Honeywell and Autoliv
Expertise includes Lean, TPM, Six Sigma, and Industry 4.0 practices for large-scale transformation
👀 What to Watch
This is a planned leadership succession and is unlikely to impact the stock price immediately. Investors should monitor how the new COO's expertise in manufacturing excellence influences operational margins over the long term.
Bajaj Healthcare Q3 PAT Rises 34% to ₹15.67 Cr; Key Management Re-appointed
Bajaj Healthcare reported a strong 31.3% YoY growth in revenue from operations, reaching ₹161.22 crore for Q3 FY26. Net profit for the quarter surged by 33.7% YoY to ₹15.67 crore, aided by improved performance in continuing operations and significantly reduced losses from discontinued units. The company also announced the re-appointment of its top leadership, including the Chairman and Managing Directors, for another three-year term starting April 2026. Nine-month performance remains robust with total profit increasing to ₹38.62 crore compared to ₹28.32 crore in the previous year.
Key Highlights
Revenue from operations grew 31.3% YoY to ₹16,122.27 lakhs in Q3 FY26.
Net profit for the period increased 33.7% YoY to ₹1,567.38 lakhs.
9M FY26 total income reached ₹46,215.16 lakhs compared to ₹39,396.27 lakhs in 9M FY25.
Losses from discontinued operations narrowed significantly to ₹42.71 lakhs from ₹324.44 lakhs YoY.
Board approved the re-appointment of the core promoter management team for a 3-year term starting April 2026.
👀 What to Watch
Investors should view the strong top-line and bottom-line growth as a positive sign of operational efficiency and scale. The continuity in leadership provides stability, though investors should monitor the final disposal of discontinued assets.
Bajaj Healthcare Seeks Shareholder Approval for 7 Director Appointments and Re-appointments
Bajaj Healthcare has issued a postal ballot notice to seek shareholder approval for the appointment of three Independent Directors and the re-appointment of four key executive leaders. The executive re-appointments, including the Chairman & Managing Director and Managing Director, are for three-year terms starting April 1, 2026. The three new Independent Directors are proposed for five-year terms to enhance board oversight and governance. Shareholders can cast their votes electronically from January 20 to February 19, 2026.
Key Highlights
Re-appointment of Sajankumar Rameshwarlal Bajaj as CMD for a 3-year term starting April 1, 2026
Proposed appointment of 3 new Independent Directors for 5-year terms to strengthen board governance
Re-appointment of Anil Champalal Jain as MD and two other Whole-Time Directors for 3-year terms
E-voting period scheduled from January 20, 2026, to February 19, 2026
Cut-off date for eligibility to vote is January 16, 2026
👀 What to Watch
Shareholders should review the profiles of the proposed directors and participate in the e-voting process to ensure leadership stability. Leadership continuity is generally a positive sign for the execution of the company's long-term strategy.
Bajaj Healthcare Q3 FY26: Revenue Up 31%, API Exports Surge 110% YoY
Bajaj Healthcare reported a strong Q3 FY26 with revenue growing 31.3% YoY to Rs. 1,612.2 Mn, primarily driven by a massive 109.8% surge in API exports. EBITDA margins improved slightly to 19.8%, leading to a 33.7% YoY increase in net profit to Rs. 156.7 Mn. The company achieved a significant regulatory milestone as the first Indian firm to receive CDSCO approval for Phase III trials of Suvorexant. For the nine-month period, PAT grew by 36.4%, reflecting sustained momentum in regulated markets and specialty drug development.
Key Highlights
Revenue from operations grew 31.3% YoY to Rs. 1,612.2 Mn in Q3 FY26.
API Export revenue more than doubled, growing 109.8% YoY to Rs. 486.8 Mn.
EBITDA increased by 34.6% YoY to Rs. 323.3 Mn with margins expanding to 19.8%.
Profit for the period (PAT) rose 33.7% YoY to Rs. 156.7 Mn.
Filed 9 DMFs during the quarter, bringing the cumulative total to 69 filings.
👀 What to Watch
The company shows strong momentum in high-margin API exports and a successful transition towards regulated markets. Investors should monitor the progress of Phase III clinical trials for Suvorexant and Cenobamate as these represent high-value specialty opportunities.
Hindware Home Innovation Gets NCLT Nod to Convene Meetings for Business Demerger
Hindware Home Innovation Limited (HHIL) has received an order from NCLT Kolkata to convene meetings for its proposed composite scheme of arrangement. The restructuring involves demerging the consumer product business into HHIL Limited and the remaining business into Hindware Limited, with an appointed date of April 1, 2025. A corrigendum has rescheduled the crucial meeting for 43,059 equity shareholders to March 7, 2026. This move is a significant step toward corporate simplification and potential value unlocking for shareholders.
Key Highlights
NCLT Kolkata directs convening of meetings for a demerger involving three group entities.
Consumer product business to be demerged into HHIL Limited; remaining business into Hindware Limited.
Meeting for 43,059 equity shareholders and 2,133 unsecured creditors rescheduled to March 7, 2026.
Appointed date for the proposed scheme is set as April 1, 2025.
Valuation report and fairness opinion completed by EY and Corporate Professionals Capital respectively.
👀 What to Watch
Investors should monitor the voting results of the shareholder meeting on March 7, 2026, as the demerger is expected to create specialized entities. This restructuring typically leads to better operational focus and market valuation for individual business segments.
Indosolar Reports Robust Q3 FY26 Growth: PAT Surges 305% YoY to ₹41.47 Crores
Indosolar Limited, a subsidiary of Waaree Energies, reported a stellar performance for Q3 FY26 with total income rising 92.20% YoY to ₹199.70 crores. Profitability saw a massive jump as PAT surged 304.98% YoY to ₹41.47 crores, supported by significant margin expansion. EBITDA margins improved from 23.44% to 35.64% during the quarter, reflecting better operational efficiency. For the nine-month period (9M FY26), the company's PAT grew by an exceptional 1288% to ₹204.60 crores compared to the previous year.
Key Highlights
Total Income for Q3 FY26 stood at ₹199.70 crores, up 92.20% from ₹103.90 crores in Q3 FY25.
Quarterly PAT increased by 304.98% YoY to ₹41.47 crores with PAT margins doubling to 20.77%.
EBITDA for the quarter grew 192.28% YoY to ₹71.17 crores, with margins expanding to 35.64%.
9M FY26 performance shows massive scale-up with PAT reaching ₹204.60 crores vs ₹14.74 crores YoY.
The company operates a 1.3 GW solar module manufacturing facility in Noida as a Waaree Energies subsidiary.
👀 What to Watch
Investors should take note of the significant turnaround and margin expansion, which positions the company well in the high-growth solar sector. The strong parentage of Waaree Energies and the 1.3 GW capacity utilization remain key drivers to watch for long-term value.
Indosolar Q3 PAT Surges to ₹41.47 Cr; Dr. Jignesh Rathod Appointed as CEO
Indosolar Limited reported a robust Q3 FY26 with revenue from operations at ₹199.53 crore and a Profit After Tax (PAT) of ₹41.47 crore. For the nine-month period ending December 2025, the company recorded a total income of ₹597.13 crore and a PAT of ₹204.60 crore, reflecting strong growth since commencing commercial operations in July 2024. The board also announced the appointment of Dr. Jignesh Rathod as CEO following the resignation of Mr. Amit Ashok Paithankar. Furthermore, the company plans to relocate its registered office from Delhi to Maharashtra to streamline operations within the Waaree Group.
Key Highlights
Q3 FY26 Revenue from operations grew to ₹199.53 crore from ₹103.01 crore in the previous year's corresponding quarter.
Net Profit for the quarter stood at ₹41.47 crore, a significant increase from ₹10.24 crore in Q3 FY25.
9M FY26 PAT reached ₹204.60 crore, aided by the recognition of deferred tax assets worth ₹61.64 crore earlier in the fiscal year.
Management transition: Dr. Jignesh Rathod, a Waaree Group veteran with 18+ years of experience, appointed as CEO effective January 16, 2026.
Board approved shifting the registered office from Delhi to Maharashtra, pending shareholder and regulatory approvals.
👀 What to Watch
The strong financial performance and leadership transition within the Waaree Group ecosystem are positive indicators of operational stability. Investors should monitor the company's ability to maintain these margins as it scales its solar PV module manufacturing.
Indosolar Q3 PAT Surges 305% to ₹41.47 Cr; Dr. Jignesh Rathod Appointed as CEO
Indosolar Limited reported a robust Q3 FY26 with revenue from operations reaching ₹199.53 crore, a 93.7% increase from ₹103.01 crore year-on-year. Net profit saw a massive jump of 305%, rising to ₹41.47 crore from ₹10.24 crore in the same quarter last year. The company also announced a leadership change, appointing Dr. Jignesh Rathod, a veteran from the Waaree Group, as the new CEO. Furthermore, the board approved shifting the registered office to Maharashtra, indicating closer integration with its parent group's operations.
Key Highlights
Quarterly Revenue grew 93.7% YoY to ₹199.53 crore, while 9-month revenue reached ₹596.75 crore.
Net Profit for Q3 FY26 stood at ₹41.47 crore, a significant increase from ₹10.24 crore in Q3 FY25.
9-month PAT reached ₹204.60 crore, significantly higher than ₹14.74 crore in the previous year's corresponding period.
Dr. Jignesh Rathod, with 18 years of experience at Waaree Group, appointed as CEO effective January 16, 2026.
Board approved shifting the registered office from Delhi to Maharashtra to streamline group operations.
👀 What to Watch
The strong financial turnaround and leadership transition to a group veteran are highly positive; investors should monitor the company's ability to maintain these high margins as it scales.
Indosolar Q3 Net Profit Jumps to ₹41.47 Cr; Appoints Dr. Jignesh Rathod as New CEO
Indosolar Limited reported a stellar performance for Q3 FY26, with revenue from operations nearly doubling to ₹199.53 crore compared to ₹103.01 crore in the previous year. Net profit surged significantly to ₹41.47 crore from ₹10.24 crore in Q3 FY25, reflecting the successful scale-up of its Greater Noida manufacturing facility. The company also announced a leadership change, appointing Dr. Jignesh Rathod as the new CEO following the resignation of Amit Ashok Paithankar. Furthermore, the board has proposed shifting the registered office from Delhi to Maharashtra to better align with Waaree Group operations.
Key Highlights
Revenue from operations grew 93.7% YoY to ₹199.53 crore in Q3 FY26.
Net profit for the quarter increased by over 300% YoY to ₹41.47 crore.
Nine-month revenue reached ₹596.75 crore, up from ₹130.57 crore in the corresponding period last year.
Dr. Jignesh Devchandbhai Rathod appointed as CEO and Non-Executive Director effective January 16, 2026.
Board approved shifting the registered office from Delhi to Maharashtra, subject to shareholder approval.
👀 What to Watch
Investors should view the strong earnings growth and the appointment of a Waaree Group veteran as CEO as a positive signal for operational stability. The stock remains a strong hold as the company continues to benefit from its newly operational manufacturing capacity.
Indosolar Q3 PAT Surges to ₹41.47 Cr; New CEO Appointed as Operations Scale Up
Indosolar Limited reported a robust performance for Q3 FY26, with revenue from operations nearly doubling to ₹199.53 crore compared to ₹103.01 crore in the same quarter last year. Net profit for the quarter jumped significantly to ₹41.47 crore from ₹10.24 crore YoY, reflecting the successful ramp-up of its Greater Noida factory which commenced operations in July 2024. The company also announced a leadership transition, appointing Dr. Jignesh Rathod as the new CEO following the resignation of Amit Paithankar. Furthermore, the board has proposed shifting the registered office from Delhi to Maharashtra to better align with the Waaree Group's corporate structure.
Key Highlights
Revenue from operations grew 93.7% YoY to ₹199.53 crore in Q3 FY26.
Net Profit (PAT) for the quarter increased by over 300% YoY to ₹41.47 crore.
Nine-month (9M FY26) PAT reached ₹204.60 crore, a massive jump from ₹14.74 crore in the previous year.
Dr. Jignesh Rathod, a Waaree Group veteran with 18+ years of experience, appointed as the new CEO.
Board approved shifting the registered office from Delhi to Maharashtra, subject to shareholder approval.
👀 What to Watch
The company is demonstrating strong operational turnaround and profitability following its acquisition by the Waaree Group. Investors should maintain a positive outlook but monitor the leadership transition and the impact of the registered office relocation on administrative costs.
Indosolar Q3 PAT Jumps 305% YoY to ₹41.47 Cr; Dr. Jignesh Rathod Appointed as CEO
Indosolar Limited reported a robust year-on-year performance for Q3 FY26, with revenue from operations nearly doubling to ₹199.53 crore compared to ₹103.01 crore in the same quarter last year. Net profit for the quarter surged to ₹41.47 crore from ₹10.24 crore YoY, reflecting the successful scale-up of its Greater Noida factory operations. The company also announced a key leadership change, appointing Waaree Group veteran Dr. Jignesh Rathod as CEO following the resignation of Amit Paithankar. Additionally, the board has proposed shifting the registered office from Delhi to Maharashtra to align with group operations.
Key Highlights
Revenue from operations grew 93.7% YoY to ₹199.53 crore in Q3 FY26.
Net Profit (PAT) for the quarter increased by 305% YoY to ₹41.47 crore.
9-month FY26 PAT reached ₹204.60 crore, a massive jump from ₹14.74 crore in the previous year period.
Dr. Jignesh Rathod, with 18+ years of experience at Waaree Group, appointed as CEO effective January 16, 2026.
Board approved shifting the Registered Office from New Delhi to Maharashtra, subject to shareholder approval.
👀 What to Watch
Investors should take note of the significant operational turnaround and profit growth following the commencement of the Greater Noida facility. The appointment of a long-term group veteran as CEO suggests stability and deeper integration with the Waaree ecosystem.
Bajaj Healthcare Re-appoints Top Leadership Team for 3-Year Terms Starting April 2026
Bajaj Healthcare's Board has approved the re-appointment of its core leadership team, including Chairman & MD Sajankumar Bajaj and MD Anil Jain, for three-year terms. These appointments, effective from April 1, 2026, ensure management continuity for the company's API and formulation divisions. Additionally, two Whole-Time Directors, Ms. Namrata Bajaj and Mr. Pakshal Jain, were re-appointed for similar tenures. The board also approved the un-audited financial results for the quarter and nine months ended December 31, 2025, during the same session.
Key Highlights
Re-appointment of Mr. Sajankumar Rameshwarlal Bajaj as Chairman & MD for 3 years effective April 1, 2026.
Re-appointment of Mr. Anil Champalal Jain as Managing Director for a 3-year term ending March 31, 2029.
Two Whole-Time Directors re-appointed for 3-year tenures to oversee Sales, Marketing, and API development.
Board approved un-audited financial results for the quarter and nine months ended December 31, 2025.
All leadership extensions are subject to shareholder approval via a forthcoming postal ballot.
👀 What to Watch
Investors should view these re-appointments as a positive sign of management stability and continuity. The primary focus should now shift to analyzing the Q3 FY26 financial results released in the same meeting.
Indosolar Q3 PAT Surges 305% YoY to ₹41.47 Cr; Appoints Dr. Jignesh Rathod as CEO
Indosolar Limited reported a robust year-on-year performance for Q3 FY26, with revenue nearly doubling to ₹199.53 crore compared to ₹103.01 crore in the same period last year. Net profit (PAT) jumped to ₹41.47 crore from ₹10.24 crore YoY, though it saw a slight sequential decline from ₹46.34 crore in Q2. The company announced a leadership change, appointing Dr. Jignesh Rathod as CEO following the resignation of Amit Ashok Paithankar. Furthermore, the board has approved shifting the registered office from Delhi to Maharashtra to better align with the Waaree Group's operations.
Key Highlights
Revenue from operations grew 93.7% YoY to ₹199.53 crore in Q3 FY26.
Net Profit (PAT) for the quarter stood at ₹41.47 crore, a 305% increase from ₹10.24 crore in Q3 FY25.
9-month FY26 PAT reached ₹204.60 crore, compared to just ₹14.74 crore in the previous year's 9-month period.
Dr. Jignesh Rathod, a veteran with 18+ years in the Waaree Group, appointed as the new CEO and Additional Director.
Board approved the relocation of the registered office from Delhi to Maharashtra, subject to shareholder approval.
👀 What to Watch
Investors should note the strong YoY growth following the commencement of commercial operations at the Greater Noida factory. The leadership transition to a Waaree Group veteran suggests a focus on operational continuity and group synergy.
Indosolar Q3 PAT Surges 305% YoY to ₹41.47 Cr; Dr. Jignesh Rathod Appointed as CEO
Indosolar Limited reported a robust YoY performance for Q3 FY26, with revenue from operations nearly doubling to ₹199.53 crore and PAT jumping 305% to ₹41.47 crore. While YoY growth is high due to the commencement of commercial operations in July 2024, the company saw a minor sequential dip in revenue (1.5%) and PAT (10.5%) compared to Q2 FY26. The board also approved the appointment of Dr. Jignesh Rathod, a Waaree Group veteran, as the new CEO. Furthermore, the company plans to shift its registered office from Delhi to Maharashtra to better align with its parent group's operations.
Key Highlights
Revenue from operations grew 93.7% YoY to ₹19,952.61 lakhs in Q3 FY26.
Net Profit (PAT) for the quarter stood at ₹4,147.01 lakhs, up from ₹1,023.50 lakhs in Q3 FY25.
9-month FY26 revenue reached ₹59,674.97 lakhs, significantly higher than the ₹13,056.60 lakhs reported in 9M FY25.
Dr. Jignesh Rathod appointed as CEO, bringing 18 years of experience within the Waaree Group.
Proposal to shift registered office to Maharashtra approved, pending shareholder and regulatory nods.
👀 What to Watch
The company is successfully scaling up operations post-restart, though investors should monitor if the slight QoQ margin contraction is a trend. The leadership transition to a group insider is a stabilizing move for the Waaree-owned entity.
Bajaj Healthcare Approves Q3 FY26 Results and Re-appoints Top Leadership for 3-Year Terms
Bajaj Healthcare has approved its un-audited financial results for the quarter and nine months ended December 31, 2025. The board has also approved the re-appointment of four key executive directors, including the Chairman and Managing Director, for new three-year terms starting in 2026. These leaders, including Mr. Sajankumar Bajaj and Mr. Anil Jain, have over 30 years of experience with the company. The re-appointments are subject to shareholder approval via a postal ballot.
Key Highlights
Approved un-audited financial results for the quarter and nine months ended December 31, 2025.
Re-appointed Sajankumar Rameshwarlal Bajaj as Chairman & MD for 3 years effective April 1, 2026.
Re-appointed Anil Champalal Jain as Managing Director for a 3-year term starting April 1, 2026.
Extended the terms of Whole-Time Directors Namrata Bajaj and Pakshal Jain for 3 years each.
The board meeting was conducted on January 16, 2026, between 4:15 PM and 5:00 PM.
👀 What to Watch
Investors should review the detailed Q3 financial performance figures once fully published to assess the company's fundamental health. The continuity in top management is a positive sign for the company's long-term strategic stability.
Waaree Energies Incorporates 8 New Step-Down Subsidiaries for IPP Projects
Waaree Energies Limited has announced the incorporation of eight new wholly-owned step-down subsidiaries through its subsidiary, Waaree Forever Energies Private Limited. These entities are established as Independent Power Producers (IPP) to facilitate and hold specific power projects under the IPP framework. All eight companies were incorporated between January 13 and January 15, 2026, and are 100% owned by the group. This move signals a structured expansion strategy to scale the company's renewable energy project portfolio.
Key Highlights
Incorporation of 8 new wholly-owned step-down subsidiaries under Waaree Forever Energies Private Limited.
Entities are categorized as Independent Power Producers (IPP) for specific power projects.
All subsidiaries are 100% owned by the group with zero initial turnover as they are newly formed.
Incorporation dates for the entities range from January 13, 2026, to January 15, 2026.
👀 What to Watch
Investors should view this as a positive step toward expanding the company's project pipeline in the renewable energy sector. Monitor future updates regarding specific project allocations or capital expenditure plans for these new subsidiaries.
